Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region

Recruiting

You are on the General Public view
  • Source

    -
    Public Title Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region
    Acronym Sorry, not currently available
    Source of Record URL http://clinicaltrials.gov/show/NCT00693836
  • Trial

    -
    Health Condition(s) or Problem Lung Cancer
    Lay Summary RATIONALE: Gathering information about genetic and environmental factors from patients with lung cancer and their partners and first-degree relatives may help doctors learn more about the disease. PURPOSE: This clinical trial is looking at the patterns, causes, and control of disease in patients with lung cancer in the North Trent (England) region. (from ClinicalTrials.gov)
    Who can enter the trial DISEASE CHARACTERISTICS: - Patient meeting the following criteria: - Pathologically confirmed lung cancer or planning to undergo lung cancer surgery pending pathological confirmation - Evidence of active disease (i.e., not in remission) - Meets 1 of the following criteria: - 60 years of age and under - Has a first-degree relative with lung cancer who is 60 years of age and under - Has two or more first- or second-degree relatives with lung cancer at any age - Control meeting the following criteria: - Co-habiting partner of patient OR first-degree relative of patient or their partner - 18 years of age and over - Resides within the North Trent Cancer Network region PATIENT CHARACTERISTICS: - Able and willing to complete study procedures PRIOR CONCURRENT THERAPY: - Not specified
    Who cannot enter the trial DISEASE CHARACTERISTICS: - Patient meeting the following criteria: - Pathologically confirmed lung cancer or planning to undergo lung cancer surgery pending pathological confirmation - Evidence of active disease (i.e., not in remission) - Meets 1 of the following criteria: - 60 years of age and under - Has a first-degree relative with lung cancer who is 60 years of age and under - Has two or more first- or second-degree relatives with lung cancer at any age - Control meeting the following criteria: - Co-habiting partner of patient OR first-degree relative of patient or their partner - 18 years of age and over - Resides within the North Trent Cancer Network region PATIENT CHARACTERISTICS: - Able and willing to complete study procedures PRIOR CONCURRENT THERAPY: - Not specified
    What will happen Genetic; genetic linkage analysis; Genetic; loss of heterozygosity analysis; Genetic; mutation analysis; Genetic; polymerase chain reaction; Genetic; polymorphism analysis; Other; biologic sample preservation procedure; Other; medical chart review; Other; questionnaire administration; Procedure; evaluation of cancer risk factors
    Primary aim Establishment of a resource bank of high quality genomic and plasma DNA and tumor and serum samples
    Secondary Aim Analysis of single nucleotide polymorphisms for candidate lung cancer susceptibility genes in genomic DNA samples; No; Genetic changes of lung cancer in plasma DNA samples; No
    Participant Information Sheet Sorry, not currently available
    Website http://cancer.gov/clinicaltrials/CRC-WPH-USMS-ReSoLuCENT
    Recruitment Status Recruiting
    Nation England
    Location Sheffield
  • Contact

    -
    Contact for Public Queries Penella J. Woll, MD, PhD Principal Investigator Cancer Research Centre at Weston Park Hospital
    Contact for Scientific Queries Sorry, not currently available
Please note:
  1. The UKCTG information is designed to inform you of existing trials. If you wish to join a specific trial, you must discuss this with your own doctor who may decide to get in touch with the contact listed.
  2. The UKCTG is not responsible for the quality of the data displayed in the Gateway but can contact the data providers. Please contact us if you have any query regarding the quality of trial records.